Fortnightly review: Medical management of menorrhagia

British Medical Journal

Volumn 319, Issue 7221, 1999, Pages 1343-1345

  Prentice, Andrew ^a  

^a Rosie Maternity Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; GESTAGEN; LEVONORGESTREL; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; TRANEXAMIC ACID;

FEMALE; HORMONAL THERAPY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MENSTRUAL CYCLE; NEW ZEALAND; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY; SPOTTING; UNITED KINGDOM; VAGINA BLEEDING;

EID: 0033589673     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7221.1343     Document Type: Short Survey

References (30)

1. 1 Vessey MP, Villard-Mackintosh L, McPherson K, Coulter A, Yeates D. The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol 1992;99:402-7.
2. 2 Coulter A, McPherson K, Vessey M. Do British women undergo too many or too few hysterectomies? Soc Sci Med 1988;27:987-94.
3. 3 Paul C, Skegg D, Smeijers J, Spear G. Contraceptive practice in New Zealand. NZ Med J 1988;101:809-13.
4. 4 Hallberg L, Hogdahl A, Nilsson L, Rybo G. Menstrual blood loss - a population study: variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320-51.
5. 5 MORI. Women's health in 1990. Market Opinion and Research International, 1990. (Research study conducted on behalf of Parke-Davis Research Laboratories.)
6. 6 Intercontinental Medical Statistics. United Kingdom and Ireland. Middlesex: IMS, 1994.
7. 7 Farquhar CM, Kimble R. How do NZ gynaecologists treat menorrhagia? Aust NZ J Obstet Gynaecol 1996;36:4:1-4.
8. 8 National Advisory Committee on Health and Disability. Guidelines for the management of heavy menstrual bleeding. New Zealand: NACHD, 1998.
9. 9 Royal College of Obstetricians and Gynaecologists. The initial management of menorrhagia. Evidence-based clinical guidelines, No 1. London: RCOG, 1998.
10. 10 NHS Dissemination Centre. The management of menorrhagia. Effect Health Care Bull 1995;9.
11. 11 Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women wilh menorrhagia. Lancet 1998;261:485-9.
12. 12 Dockery CJ, Sheppard B, Daly L, Bonnar J. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid. Eur J Obstet Gynaecol Reprod Biol 1987;24:309-18.
13. 13 Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981;88:434-42.
14. 14 Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to distinguish between menorrhagia and normal menstrual blood loss. Obstet Gynaecol 1995;85:977-82.
15. 15 Scott JC, Mussey E. Menstrual patterns of myxedema. Am J Obstet Gynecol 1964;90:161-5.
16. 16 Krassas GE, Pontikides N, Kaltsas T, Papadopoulou P, Batrinos M. Menstrual disturbances in thyrotoxicosis. Clin Endocrinol 1994;40:641-4.
17. 17 Haynes PJ, Anderson AB, Turnbull AC. Patterns of menstrual blood loss in menorrhagia. Res Clin Forums 1979;1:73-8.
18. 18 Eldred JM, Thomas EJ. Pituitary and ovarian hormone levels in unexplained menorrhagia. Obstet Gynecol 1994;84:775-8.
19. 19 Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: is the information good enough? BMJ 1999;318:318-22.
20. 20 Preston JT, Cameron IT, Adams EJ, Smith SK. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol 1995;102:401-6.
21. 21 Andersch B, Milsom I, Rybo G. An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstet Gynecol Scand 1988;67:645-8.
22. 22 Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996;313:579-82.
23. 23 Cooke I, Lethaby A, Farquhar C. Antifibrinolytics for heavy menstrual bleeding. In: Cochrane Collaboration. Cochrane Library, Issue 1. Oxford: Update Software, 1999.
24. 24 Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. In: Cochrane Collaboration. Cochrane Library, Issue 1. Oxford: Update Software, 1999.
25. 25 Lethaby A, Irvine G, Cameron I. Cyclical progestagens for heavy menstrual bleeding. In: Cochrane Collaboration. Cochrane Library, Issue 1. Oxford: Update Software, 1999.
26. 26 Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ. Cameron IT. Randomised comparative trial of the levonorgestrel intra-uterine system and norethisterone for the treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998;105:592-8.
27. 27 Silverberg SG, Haukkamaa M, Arko H, Nilsson CG, Luukkainen T Endometrial morphology during long-term use of levonorgestrel releasing intra-uterine devices. Int J Gynaecol Pathol 1986;5:235-41.
28. 28 Barrington JW, Bowen-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol 1997;104:614-6.
29. 29 Lahteenmaki P, Haukkamaa M, Puolakka J, Riikonen U, Sainio S, Suvisari J, et al. Open randomised study of use of levonorgestrel releasing intra-uterine system as an alternative to hysterectomy. BMJ 1998;316:1122-6.
30. 30 Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997;90:257-63.